4.4 Article

Risk of Long COVID in People Infected With Severe Acute Respiratory Syndrome Coronavirus 2 After 2 Doses of a Coronavirus Disease 2019 Vaccine: Community-Based, Matched Cohort Study

Journal

OPEN FORUM INFECTIOUS DISEASES
Volume 9, Issue 9, Pages -

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/ofid/ofac464

Keywords

coronavirus; COVID-19; long COVID; post-COVID condition; vaccination

Funding

  1. NIHR Applied Research Collaboration East Midlands
  2. NIHR Leicester Biomedical Research Centre
  3. NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance [NIHR200915]
  4. UK Health Security Agency
  5. University of Oxford
  6. Huo Family Foundation [501100022111]
  7. NIHR Oxford Biomedical Research Centre
  8. NIHR

Ask authors/readers for more resources

Vaccination reduces the incidence of long COVID, highlighting the importance of increasing population-level vaccine uptake through public health initiatives.
We investigated long COVID incidence by vaccination status in a random sample of UK adults from April 2020 to November 2021. Persistent symptoms were reported by 9.5% of 3090 breakthrough severe acute respiratory syndrome coronavirus 2 infections and 14.6% of unvaccinated controls (adjusted odds ratio, 0.59 [95% confidence interval, .50-.69]), emphasizing the need for public health initiatives to increase population-level vaccine uptake.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available